Trial intelligence / Profile preview

Heparin for deep vein thrombosis prophylaxis in critically ill ICU patients

IRCT201402113449N14Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Feb 2014
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, single-arm trial of heparin in venous thromboembolism (VTE), sponsored by Tehran University of Medical Sciences. Started Feb 2014; status: completed.

02

Drugs

heparin
03

Conditions

venous thromboembolism (VTE)

Beyond the preview

Go deeper on IRCT201402113449N14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201402113449N14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call